Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 29 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

19 Single-cell biophysical profiling as an early predictor of tumor reactivity in tumor-infiltrating lymphocyte manufacturing

  • Shari Pilon-Thomas1
  • Matthew Beatty1
  • Johannes Ali2
  • Rachel Labella3
  • Nicholas L Calistri3
  • Madeleine Vacha3
  • Katie Katsis3
  • Reginald Aikins3
  • Maria Ssozi3
  • Dennis Watson3
  • Selim Olcum3
  • Robert J Kimmerling3
  1. 1H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA
  2. 21Moffitt Cancer Center, Tampa, FL, USA
  3. 3Travera, Medford, MA, USA
Open at sourcePDFDOICite

Related

  1. 352 Assessment of the Xiogenix Ares X20+ as an automated fill-finish solution for tumor-infiltrating lymphocyte therapy manufacturing
    Chantale Bernatchez, Marie-Andree Forget, Donastas Sakellariou-Thompson +7
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYOncologyDOAJ
  2. The Prognostic Role of CD8+ Tumor‐Infiltrating Lymphocyte Density in Head and Neck Mucosal Melanoma
    Nicholas K. Fung, Douglas Hartman, Diwakar Davar +1
    Otolaryngology--Head and Neck SurgeryPeer-reviewedLicence not statedFull textOncologyPMC
  3. 334 Phase 1 trial of GC101, an IL2free autologous tumor-infiltrating lymphocyte (TIL) therapy, in recurrent high-grade glioma: safety and preliminary efficacy
    Qing Lan, Ying Cheng, Yanming Chen +2
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  4. A tumor-infiltrating lymphocyte-related prognostic signature for lung adenocarcinoma.
    Kang Tian, Xinjie Zhao, Jiajun Du +1
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  5. Tumour region identification guided scoring (TRIGS) and foundation model-based Tumour Infiltrating Lymphocyte scoring are prognostic for pathological complete response/event free survival in the triple negative patients in the PARTNER randomized controlled trial
    P. C. Schouten, M. O. Irfan, Z. Kinsella +15
    medRxivPreprintCC BY-NDFull textGeneral medicinemedRxiv

Cite

BibTeXRIS
BibTeX
@article{pilonthomas2026singlecell,
  title = {{19 Single-cell biophysical profiling as an early predictor of tumor reactivity in tumor-infiltrating lymphocyte manufacturing}},
  author = {Shari Pilon-Thomas and Matthew Beatty and Johannes Ali and Rachel Labella and Nicholas L Calistri and Madeleine Vacha and Katie Katsis and Reginald Aikins and Maria Ssozi and Dennis Watson and Selim Olcum and Robert J Kimmerling},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0019},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0019},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 19 Single-cell biophysical profiling as an early predictor of tumor reactivity in tumor-infiltrating lymphocyte manufacturing
AU  - Shari Pilon-Thomas
AU  - Matthew Beatty
AU  - Johannes Ali
AU  - Rachel Labella
AU  - Nicholas L Calistri
AU  - Madeleine Vacha
AU  - Katie Katsis
AU  - Reginald Aikins
AU  - Maria Ssozi
AU  - Dennis Watson
AU  - Selim Olcum
AU  - Robert J Kimmerling
PY  - 2026
DA  - 2026/11/08
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0019
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0019
SN  - 2051-1426
ER  -